Bintai Kinden Corporation Berhad News
Bintai Kinden Subsidiary Inks Mou For Covid 19 Vaccine Distribution In Australia New Zealand The Edge Markets
8fvhfusoxl4tvm
Bintai Kinden S Partner Signs Framework Agreement To Develop Commercialise Ii Key Vaccine In China The Edge Markets
Bintai Kinden Partner To Develop China S Li Key Covid 19 Vaccine The Star
Investors Seek A Dose Of Vaccine Counters The Edge Markets
Mr Diy Myeg Vstecs Kpower Tafi Bintai Kinden And Solution Group The Edge Markets
Trading Ideas Myeg Kumpulan Powernet Tafi Bintai Kinden Mr Diy Vstecs The Star
Bintai Kinden Shares Hit 3 Year High As It Announces Covid 19 Vaccine Venture The Edge Markets
Quick Take Bintai Kinden Rises On Partnership Deal The Star
Engineering And Construction Remain Bintai Kinden S Main Focus The Edge Markets
Generex Announces Signed Agreement With Bintai Kinden To Advance The Clinical Development Commercialization Of Ii Key Sars Cov 2 Coronavirus Vaccine For Malaysia Biotechstocktrader
Bintai Kinden To Pay Us 10mil To Generex Upon Covid 19 Vaccine Commercialisation
Bintai Kinden Posts 1q Net Loss Of Rm1 3mil The Star
Bintai Kinden Bags Rm20 4m Dftz Related Contract
Askydmtpckwam
Bintai Kinden Wins Dtfz Job The Star
Bintai Kinden Mce Diversified Gateway Idimension Kanger Mmag Solution Superlon Ktg The Edge Markets
Generex Announces Signed Agreement With Bintai Kinden To Advance The Clinical Development Commercialization Of Ii Key Sars Cov 2 Coronavirus Vaccine For Malaysia
Nugenerex Immuno Oncology Announces Closing Of A Licensing Distribution Agreement With Bintai Kinden To Advance The Clinical Development Commercialization Of Ii Key Sars Cov 2 Coronavirus Vaccine For Global Markets
